Skip to main content
Clinical Trials/NCT01606904
NCT01606904
Completed
Not Applicable

The Effect of CBT- Based Weight Loss Program on Eating Behavior, Weight Loss Result and Risk for Coronary Heart Diseases and Type 2 Diabetes

University of Oulu1 site in 1 country62 target enrollmentMay 2012

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Obesity
Sponsor
University of Oulu
Enrollment
62
Locations
1
Primary Endpoint
change in weight
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

The investigators purpose is to study how CBT (cognitive behavioral therapy)-based weight loss program affects on eating behavior, weight loss and risk factors for CHD (coronary heart diseases)and type 2 diabetes. Moreover, the investigators aim is to recognize subjects suffering from anhedonia (one of the core symptoms of depression, lack of pleasure) and follow how they benefit from the program in order to achieve maintained weight loss. Also, the associations between weight loss, physical activity and musculoskeletal disorders are studied.

Detailed Description

Obesity is an increasing problem and effective weight loss methods are needed. The study is randomized follow-up study with 9 months intervention and three (3) years follow-up period. The study is organized in Oulu University Hospital, Department of Internal Medicine. Eighty (80)obese, 20-65 years, study subjects will be randomized into intervention or control group. The hypothesis of the CognObe study is: CBT (cognitive behavioral therapy)-based weight loss program is successful in sustained and favourable change in eating behavior and weight as well as decreased risk for coronary heart diseases or type 2 diabetes.

Registry
clinicaltrials.gov
Start Date
May 2012
End Date
March 2016
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Anna-Maria Keränen

P.h.D, clinical nutritionist

University of Oulu

Eligibility Criteria

Inclusion Criteria

  • BMI \> 30

Exclusion Criteria

  • other concurrent weight loss programs
  • disease which prevents weight loss
  • medication which affects on weight loss

Outcomes

Primary Outcomes

change in weight

Time Frame: baseline, 9 months, 1,2 and 3 years

kilograms

Secondary Outcomes

  • change in incretins(baseline, 12, 24 and 36 months)
  • change in total cholesterol,HDL, LDL,Trigly and glucose(baseline, 1,2 and 3 years)
  • DNA(baseline)
  • change in eating behavior(baseline, 9 months, 1,2 and 3 years)

Study Sites (1)

Loading locations...

Similar Trials